Persistent symptoms after COVID-19 are not associated with differential SARS-CoV-2 antibody or T cell immunity by Daniel M. Altmann, Catherine J. Reynolds, George Joy, Ashley D. Otter, Joseph M. Gibbons, Corinna Pade, Leo Swadling, Mala K. Maini, Tim Brooks, Amanda Semper, Áine McKnight, Mahdad Noursadeghi, Charlotte Manisty, Thomas A. Treibel, James C. Moon, COVIDsortium investigators, Rosemary J. Boyton

Get full text

An ACAT inhibitor suppresses SARS-CoV-2 replication and boosts antiviral T cell activity. by Peter A C Wing, Nathalie M Schmidt, Rory Peters, Maximilian Erdmann, Rachel Brown, Hao Wang, Leo Swadling, COVIDsortium Investigators, Joseph Newman, Nazia Thakur, Kaho Shionoya, Sophie B Morgan, Timothy Sc Hinks, Koichi Watashi, Dalan Bailey, Scott B Hansen, Andrew D Davidson, Mala K Maini, Jane A McKeating

Get full text

An ACAT inhibitor suppresses SARS-CoV-2 replication and boosts antiviral T cell activity by Wing, PAC, Schmidt, NM, Peters, R, Erdmann, M, Brown, R, Wang, H, Swadling, L, Newman, J, Thakur, N, Shionoya, K, Morgan, SB, Hinks, TSC, Watashi, K, Bailey, D, Hansen, SB, Davidson, AD, Maini, MK, McKeating, JA

Other Authors: “…COVIDsortium Investigators…”